aTYR PHARMA INC (LIFE) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
aTYR PHARMA INC quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • aTYR PHARMA INC Operating Income (Loss) for the quarter ending March 31, 2024 was -$16.6 M, a 30.1% decline year-over-year.
  • aTYR PHARMA INC Operating Income (Loss) for the twelve months ending March 31, 2024 was -$58.8 M, a 25.5% decline year-over-year.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2023 was -$54.9 M, a 18.4% decline from 2022.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2022 was -$46.4 M, a 36.4% decline from 2021.
  • aTYR PHARMA INC annual Operating Income (Loss) for 2021 was -$34 M, a 114% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$58.8 M -$16.6 M -$3.85 M -30.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$54.9 M -$16 M -$8.01 M -101% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$46.9 M -$12.6 M +$877 K +6.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$47.8 M -$13.6 M -$974 K -7.74% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$46.8 M -$12.8 M -$409 K -3.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$46.4 M -$7.95 M +$690 K +7.99% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$47.1 M -$13.5 M -$5.76 M -74.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$41.3 M -$12.6 M -$2.14 M -20.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$39.2 M -$12.4 M -$5.18 M -71.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$34 M -$8.64 M -$3.7 M -74.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$30.3 M -$7.73 M -$1.22 M -18.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29.1 M -$10.4 M -$4.13 M -65.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$25 M -$7.2 M -$9.06 M -487% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$15.9 M -$4.94 M +$1.02 M +17.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$16.9 M -$6.51 M -$1.01 M -18.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$15.9 M -$6.32 M -$677 K -12% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$15.2 M $1.86 M +$7.74 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$23 M -$5.96 M +$1 K +0.02% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 -$23 M -$5.5 M +$1.18 M +17.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$24.2 M -$5.64 M +$4.32 M +43.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$28.5 M -$5.88 M +$4.34 M +42.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$32.8 M -$5.96 M +$5.24 M +46.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-24
Q3 2018 -$38.1 M -$6.68 M +$4.15 M +38.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$42.2 M -$9.96 M +$1.95 M +16.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$44.2 M -$10.2 M +$2.99 M +22.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$47.1 M -$11.2 M +$1.33 M +10.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 -$48.5 M -$10.8 M +$3.04 M +21.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$51.5 M -$11.9 M +$3.53 M +22.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$55 M -$13.2 M +$2.9 M +18% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$57.9 M -$12.5 M +$3.96 M +24% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-26
Q3 2016 -$61.9 M -$13.9 M -$2.55 M -22.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$59.3 M -$15.4 M -$4.54 M -41.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$54.8 M -$16.1 M -$7.19 M -80.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$47.6 M -$16.5 M -$10.5 M -173% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-20
Q3 2015 -$37.2 M -$11.3 M -$5.08 M -81.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$32.1 M -$10.9 M -$5.54 M -103% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$26.5 M -$8.92 M -$2.99 M -50.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$23.6 M -$6.03 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$6.23 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$5.36 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$5.93 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.